Sadegh Azimzadeh Jamalkandi
Overview
Explore the profile of Sadegh Azimzadeh Jamalkandi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
480
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Salimian J, Salehi Z, Ahmadi A, Emamvirdizadeh A, Davoudi S, Karimi M, et al.
Mol Biol Rep
. 2022 Jan;
49(4):3333-3348.
PMID: 34989960
Atopic dermatitis (AD) is a complicated, inflammatory skin disease, which numerous genetic and environmental factors play roles in its development. AD is categorized into different phenotypes and stages, although they...
12.
Khoshbakht S, Azimzadeh Jamalkandi S, Masudi-Nejad A
BMC Med Genomics
. 2021 Nov;
14(1):273.
PMID: 34801010
Background: Circulating tumor cells (CTCs) are the critical initiators of distant metastasis formation. In which, the reciprocal interplay among different metastatic pathways and their metastasis driver genes which promote survival...
13.
Najafi S, Abedini F, Azimzadeh Jamalkandi S, Shariati P, Ahmadi A, Fesharaki M
BMC Microbiol
. 2021 Nov;
21(1):315.
PMID: 34763672
Background: Although recent studies have indicated that imbalance in the respiratory microbiome composition is linked to several chronic respiratory diseases, the association between the lung microbiome and lung cancer has...
14.
Halabian R, Arshad V, Ahmadi A, Saeedi P, Azimzadeh Jamalkandi S, Alivand M
Cell Mol Biol Lett
. 2021 Nov;
26(1):46.
PMID: 34763654
Epigenetics refers to nucleotide sequence-independent events, and heritable changes, including DNA methylation and histone modification (as the two main processes), contributing to the phenotypic features of the cell. Both genetics...
15.
Moradi S, Jarrahi E, Ahmadi A, Salimian J, Karimi M, Zarei A, et al.
J Pathol
. 2021 May;
254(5):505-518.
PMID: 33959951
Chronic obstructive pulmonary disease (COPD) is a chronic lung disease characterised by airway inflammation and progressive obstruction of the lung airflow. Current pharmacological treatments include bronchodilators, alone or in combination...
16.
Bazireh H, Shariati P, Azimzadeh Jamalkandi S, Ahmadi A, Boroumand M
Front Microbiol
. 2020 Dec;
11:597946.
PMID: 33343539
Probiotics are non-pathogenic microorganisms that can interact with the gastrointestinal microbiota. They have numerous beneficial health effects that include enhancement of the host immune response, antiallergic, antimicrobial, anti-cancer, and anti-inflammatory...
17.
Azimzadeh Jamalkandi S, Kouhsar M, Salimian J, Ahmadi A
BMC Microbiol
. 2020 Dec;
20(1):376.
PMID: 33334315
Background: Streptococcus pneumonia (pneumococcus) is a human bacterial pathogen causing a range of mild to severe infections. The complicated transcriptome patterns of pneumococci during the colonization to infection process in...
18.
Hooshmand S, Ghobadi M, Hooshmand S, Azimzadeh Jamalkandi S, Alavi S, Masoudi-Nejad A
Mol Divers
. 2020 Sep;
25(3):1717-1730.
PMID: 32997257
Recently, various computational methods have been proposed to find new therapeutic applications of the existing drugs. The Multimodal Restricted Boltzmann Machine approach (MM-RBM), which has the capability to connect the...
19.
Maghsoudloo M, Azimzadeh Jamalkandi S, Najafi A, Masoudi-Nejad A
Genomics
. 2020 Jun;
112(5):3284-3293.
PMID: 32540493
Asthma, chronic obstructive pulmonary disease (COPD), and idiopathic pulmonary fibrosis (IPF) are three serious lung inflammatory diseases. The understanding of the pathogenesis mechanism and the identification of potential prognostic biomarkers...
20.
Salimian J, Baradaran B, Azimzadeh Jamalkandi S, Moridikia A, Ahmadi A
Urol Oncol
. 2020 Jun;
38(9):738.e9-738.e21.
PMID: 32527702
Objectives: Cisplatin is one of the common chemotherapy drugs for bladder cancer, and resistance to this drug is one of the major obstacles to effective chemotherapy. MicroRNAs (miRNAs) are a...